ARCHIVES

Also in this 8-page Issue: Safety Warnings Are Added to Labels for Epo and Avastin.

This article is from The Cancer Letter archive.

Vol. 31 No. 03 | January 21, 2005

Download PDF Visit The Full Archive

Related Articles

Bayer’s HER-2/neu Blood Test Cleared By FDA For Marketing.

December 15, 2000

NCAB Approves Call For New Efforts In Black/Hispanic Cancer

February 6, 1981

Sept. 9 NCAB Meeting: Varmus: Expect Another CR For Funding The NIH Through Mid-December

September 19, 2014

Immunotherapy Shrinks Tumors In Phase I Study at St. Jude

May 30, 2014

Fisher Address Gap Between Clinicians Investigators, A Threat To Patient Welfare

May 28, 1993

Competing Strategies For Breast Cancer? Brinker Tries to Ensure acceptance Of Report, Visco Urges Broad Effort

October 8, 1993